文献速递白血病淋巴瘤

RNA编辑促进慢性淋巴细胞白血病表观转录组多样性

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
PubMed 文献 · Leukemia · 2020-07-30

研究对45例未经治疗的慢性淋巴细胞白血病(CLL)患者匹配的RNA测序与外显子组测序数据分析全局及复发性RNA编辑事件,并在98例CLL患者验证队列中验证。发现CLL的RNA编辑谱较正常B细胞显著改变,且RNA编辑模式具有预后相关性。体外实验显示敲除ADAR降低MEC1细胞活力并增加其对氟达拉滨和依鲁替尼的敏感性。

要点

  • CLL患者RNA编辑谱较正常B细胞显著改变。
  • RNA编辑模式具有预后相关性。
  • 敲除ADAR降低MEC1细胞活力并增加对氟达拉滨和依鲁替尼的敏感性。

核心结论

  • 作者提出RNA编辑参与CLL的病理生理,靶向RNA编辑机制可能是未来最大化治疗疗效的策略。

研究设计与样本

  • 研究分析了45例未经治疗的CLL患者匹配的RNA测序与外显子组测序数据,并在98例CLL患者验证队列中验证RNA编辑。

主要发现

  • 与正常B细胞相比,CLL中RNA编辑谱发生显著改变。
  • RNA编辑模式具有预后相关性。
  • 敲除ADAR降低MEC1细胞的稳态活力,并使其在体外对氟达拉滨和依鲁替尼治疗更敏感。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RNA editing-primarily conversion of adenosine to inosine (A > I)-is a widespread posttranscriptional mechanism, mediated by Adenosine Deaminases acting on RNA (ADAR) enzymes to alter the RNA sequence of primary transcripts. Hence, in addition to somatic mutations and alternative RNA splicing, RNA editing can be a further source for recoding events. Although RNA editing has been detected in many solid cancers and normal tissue, RNA editing in chronic lymphocytic leukemia (CLL) has not been addressed so far. We determined global RNA editing and recurrent, recoding RNA editing events from matched RNA-sequencing and whole exome sequencing data in CLL samples from 45 untreated patients. RNA editing was verified in a validation cohort of 98 CLL patients and revealed substantially altered RNA editing profiles in CLL compared with normal B cells. We further found that RNA editing patterns were prognostically relevant. Finally, we showed that ADAR knockout decreased steady state viability of MEC1 cells and made them more susceptible to treatment with fludarabine and ibrutinib in vitro. We propose that RNA editing contributes to the pathophysiology of CLL and targeting the RNA editing machinery could be a future strategy to maximize treatment efficacy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Gassner FJ, Zaborsky N, Buchumenski I, et al. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia. Leukemia. 2020. PMID: 32728184. doi:10.1038/s41375-020-0995-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。